They will use a smaller needle to give subcutaneous injections to ensure the medication enters the fatty tissue and not the muscle. Unlike muscle tissue, subcutaneous tissue has few blood vessels, ...
Receiving monoclonal antibodies to treat COVID-19 used to be a time-consuming process at the UPMC Hamot Infusion Center. The intravenous treatment took about 30 minutes, which came after a nearly hour ...
While administering monoclonal antibodies via intravenous infusion is standard practice to prevent severe hospitalization and death in outpatients with COVID-19, new research from UPMC shows giving ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. New research suggests that the casirivimab-imdevimab monoclonal antibody treatment for COVID-19 ...
Drug approvals this year have reflected the trend in clinical development of biologics shifting from intravenous to ...
The Monkeypox vaccine has just been given the green light by the Federal Drug Administration (FDA) to be administered via intradermal injection. This method will allow healthcare professionals to get ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results